journal article·2014-08-13

Cytocompatibility and Cellular Internalization Mechanisms of SiC/SiO2Nanowires

A. Cacchioli, F. Ravanetti, R. Alinovi, S. Pinelli, F. Rossi, M. Negri, E. Bedogni, M. Campanini, M. Galetti, M. Goldoni, P. Lagonegro, R. Alfieri, F. Bigi, G. Salviati

Nano Letters· Volume 14· Issue 8
Publisher page

Abstract

First evidence of in vitro cytocompatibility of SiC/SiO2 core-shell nanowires is reported. Different internalization mechanisms by adenocarcinomic alveolar basal epithelial cells, monocytic cell line derived from an acute monocytic leukemia, breast cancer cells, and normal human dermal fibroblasts are shown. The internalization occurs mainly for macropinocytosis and sporadically by direct penetration in all cell models considered, whereas it occurred for phagocytosis only in monocytic leukemia cells. The cytocompatibility of the nanowires is proved by the analysis of cell proliferation, cell cycle progression, and oxidative stress on the cells treated with NWs as compared to controls. Reactive oxygen species generation was detected as an early event that then quickly run out with a rapid decrease only in adenocarcinomic alveolar basal epithelial and human dermal fibroblasts cells. In all the cell lines, the intracellular presence of NWs induce the same molecular events but to a different extent: peroxidation of membrane lipids and oxidation of proteins. The NWs do not elicit either midterm (72 h) or long-term (10 days) cytotoxic activity leading to irreversible cellular damages or death. Our results are important in view of a possible use of SiC/SiO2 core-shell structures acting as biomolecule-delivery vectors or intracellular electrodes.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanowire Synthesis and Applications · Anodic Oxide Films and Nanostructures

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Veterinary Science, Unit of Normal Veterinary Anatomy, University of Parma, Parma 43126, Italy

Department of Clinical and Experimental Medicine, Laboratory of Industrial Toxicology, University of Parma, Parma 43126, Italy

IMEM-CNR Institute, Parco Area delle Scienze 37/A, Parma 43124, Italy

Department of Chemistry, University of Parma, Parma 43124, Italy

Department of Clinical and Experimental Medicine, Experimental Oncology Unit, University of Parma, Parma 43126, Italy

Italian Workers’ Compensation Authority (INAIL) Research Center, Parma 43126, Italy

Funding

European Commission · Fondazione Cariparma

References (43)

Show source-provided references
1. Smith D. M. · Nat. Rev. Immunol. · 2013 · 13 · 59210.1038/nri3488 ↗
2. Patolsky F. · Nanomedicine (London, U. K.) · 2006 · 1 · 5110.2217/17435889.1.1.51 ↗
3. Zhou W. · Nano Lett. · 2014 · 14 · 161410.1021/nl500070h ↗
4. Alivisatos A. P. · ACS Nano · 2013 · 7 · 185010.1021/nn4012847 ↗
5. Persson H. · Small · 2013 · 9 · 400610.1002/smll.201300644 ↗
6. Marches R. · Nanotechnology · 2011 · 22 · 09510110.1088/0957-4484/22/9/095101 ↗
7. Kam N. W. · Proc. Natl. Acad. Sci. U. S. A. · 2005 · 102 · 1160010.1073/pnas.0502680102 ↗
8. Li N. · Angew. Chem., Int. Ed. Engl. · 2014 · 53 · 175610.1002/anie.201300441 ↗
9. Song M. M. · Biomaterials · 2010 · 31 · 150910.1016/j.biomaterials.2009.11.034 ↗
10. Schinwald A. · Part. Fibre Toxicol. · 2012 · 9 · 3410.1186/1743-8977-9-34 ↗
11. Qing Q. · Nat. Nanotechnol. · 2014 · 9 · 14210.1038/nnano.2013.273 ↗
12. Li J. · ACS Appl. Mater. Interfaces · 2013 · 5 · 981610.1021/am403070g ↗
13. Suyatin D. B. · PLoS One · 2013 · 8 · e5667310.1371/journal.pone.0056673 ↗
14. Muller K. H. · ACS Nano · 2010 · 4 · 676710.1021/nn101192z ↗
15. Fu T. M. · Proc. Natl. Acad. Sci. U. S. A. · 2014 · 111 · 125910.1073/pnas.1323389111 ↗
16. Magrez A. · ACS Nano · 2009 · 3 · 227410.1021/nn9002067 ↗
17. Park E. J. · Arch. Toxicol. · 2013 · 87 · 121910.1007/s00204-013-1019-3 ↗
18. Tian B. · Nat. Mater. · 2012 · 11 · 98610.1038/nmat3404 ↗
19. Lee J. · Biomaterials · 2008 · 29 · 374310.1016/j.biomaterials.2008.05.029 ↗
20. Zaveri T. D. · Biomaterials · 2010 · 31 · 299910.1016/j.biomaterials.2009.12.055 ↗
21. El-Gamel N. E. · Dalton Trans. · 2013 · 42 · 988410.1039/C3DT33092C ↗
22. Verma N. K. · Toxicol. Appl. Pharmacol. · 2012 · 264 · 45110.1016/j.taap.2012.08.023 ↗
23. Bilberg K. · J. Toxicol. · 2012 · 2012 · 29378410.1155/2012/293784 ↗
24. Safi M. · ACS Nano · 2011 · 5 · 535410.1021/nn201121e ↗
25. Prina-Mello A. · J. Nanobiotechnology · 2006 · 4 · 910.1186/1477-3155-4-9 ↗
26. Cellot G. · J. Neurosci. · 2011 · 31 · 1294510.1523/JNEUROSCI.1332-11.2011 ↗
27. Battigelli A. · Adv. Drug Delivery Rev. · 2013 · 65 · 189910.1016/j.addr.2013.07.006 ↗
28. Ali-Boucetta H. · Small · 2011 · 7 · 323010.1002/smll.201101004 ↗
29. Madani S. Y. · Nano Rev. · 2013 · 410.3402/nano.v4i0.21521 ↗
30. Lanone S. · Adv. Drug Delivery Rev. · 2013 · 65 · 206310.1016/j.addr.2013.07.019 ↗
31. Obarzanek-Fojt M. · Nanomedicine · 2014 · 10 · 104110.1016/j.nano.2013.12.012 ↗
32. Ju L. · PLoS One · 2014 · 9 · e8497410.1371/journal.pone.0084974 ↗
33. Frewin C. L. · 2012 · 20910.1016/B978-0-12-385906-8.00006-4 ↗
34. Adolfsson K. · Nano Lett. · 2013 · 13 · 472810.1021/nl4022754 ↗
35. Fabbri F. · Mater. Lett. · 2012 · 13710.1016/j.matlet.2011.12.059 ↗
36. Fabbri F. · Nanotechnology · 2010 · 21 · 34570210.1088/0957-4484/21/34/345702 ↗
37. Bigi F. · J. Catal. · 2007 · 22210.1016/j.jcat.2007.06.019 ↗
38. Fabbri F. · Nanoscale Res. Lett. · 2012 · 7 · 68010.1186/1556-276X-7-680 ↗
39. De Simone U. · J. Toxicol. · 2013 · 2013 · 93178510.1155/2013/931785 ↗
40. Coccini T. · Sci. World J. · 2014 · 2014 · 25976510.1155/2014/259765 ↗
41. Zucker R. M. · Cytometry A · 2013 · 83 · 96210.1002/cyto.a.22342 ↗
42. Yamashita K. · J. Clin. Biochem. Nutr. · 2013 · 53 · 2710.3164/jcbn.12-104 ↗
43. Wierzbicki R. · PLoS One · 2013 · 8 · e5330710.1371/journal.pone.0053307 ↗